mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.009 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.009 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |